26-04-2009, 11:17 PM
Look at Novavax's stock surge since Friday.
http://www.google.com/finance?hl=en&ie=U...ab=we&um=1
Researchers from Novavax and the Centers for Disease Control and Prevention vaccinated mice and ferrets with H1N1. All of the immunized mice and ferrets were protected when exposed to a lethal dose of the 1918 influenza virus, and those animals that were immunized by the intranasal route were also protected against a lethal dose of a highly pathogenic bird flu strain.
This is the first time protection against strains with different HA types has been reported. Having one vaccine which can protect against multiple strains of flu would be a great help when faced with pandemic flu situations, such as the current swine flu outbreak. A vaccine which can protect against multiple strains of flu is ideal for agencies such as the Centers for Disease Control and Prevention who stockpile vaccines for administration during the first wave of the pandemics.
http://www.associatedcontent.com/article...html?cat=5
http://www.google.com/finance?hl=en&ie=U...ab=we&um=1
Researchers from Novavax and the Centers for Disease Control and Prevention vaccinated mice and ferrets with H1N1. All of the immunized mice and ferrets were protected when exposed to a lethal dose of the 1918 influenza virus, and those animals that were immunized by the intranasal route were also protected against a lethal dose of a highly pathogenic bird flu strain.
This is the first time protection against strains with different HA types has been reported. Having one vaccine which can protect against multiple strains of flu would be a great help when faced with pandemic flu situations, such as the current swine flu outbreak. A vaccine which can protect against multiple strains of flu is ideal for agencies such as the Centers for Disease Control and Prevention who stockpile vaccines for administration during the first wave of the pandemics.
http://www.associatedcontent.com/article...html?cat=5
"If you're looking for something that isn't there, you're wasting your time and the taxpayers' money."
-Michael Neuman, U.S. Government bureaucrat, on why NIST didn't address explosives in its report on the WTC collapses
-Michael Neuman, U.S. Government bureaucrat, on why NIST didn't address explosives in its report on the WTC collapses